Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 5, 2005

View Archived Issues

Gedeon Richter and Forest Laboratories collaborate on CNS compounds

Phenoxodiol with docetaxel studied for recurrent ovarian cancer

Bristol-Myers Squibb identifies a new inhibitor of HsEg5, an attractive target for cancer

New anti-TNF immunotherapy from Abgenix

OMX-2: cytostatic agent for brain tumor therapy

Sterix's new anticancer candidates

PRO-140 enters phase Ib study in HIV

Astellas licenses rights for XP-13512 in Asia and Japan

Predix reaches agreement under SPA for PRX-00023

PRX-08066 begins phase Ib study for PAH

Imagenetix launches Celadrin/glucosamine product

Canadian sites to join ADAGIO study of Agilect

PIramed and Genentech collaborate to develop new class of anticancer drugs

ImmuFact IMP-321 studied for metastatic renal cell carcinoma

GlaxoSmithKline updates progress of oncology and supportive care compounds

Lexicon Genetics and Genentech expand drug discovery alliance

Clinical progress of a novel investigational anticancer drug BIBW-2992

FDA Advisory Committee to discuss Daytrana NDA

Procleix West Nile Virus Assay receives FDA approval

Priority review awarded to Taxotere sNDA in gastric cancer

Oncaspar sBLA accepted for review

Prostanoid EP4 receptor agonists emerge from Allergan R&D

Novel diagnostic agents disclosed in recent patents

Recent patents cover novel treatments for anxiety, depression, sleep disorders, etc.

Novel proteasome inhibitor compared to bortezomib against multiple myeloma

Antimitochondrial agent RH-123 offers promise in phase I prostate cancer trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...